Ojjaara
NDC 81864-102, Momelotinib, tablet, from GlaxoSmithKline LLC.
- Product NDC
- 81864-102
- Status
- Listed
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216873
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81864-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE150 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81864-102-30 | 81864010230 | 30 TABLET in 1 BOTTLE (81864-102-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4a672fd1-eb7b-4aa9-9b23-845e4b5dc400
Use it
Look up 81864-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81864-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81864-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.